Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPINLESS: Urinary Biomarkers in Spina Bifida
NCT06041334Recruiting
- Sponsor
- CHU Rennes
- Start
- Jan 2024
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Rennes. Primary endpoint: Association of urinary biomarkers Metalloproteinase Inhibitor 2 and matrix metalloproteinase-2 with Galloway score at 1 day. Started Jan 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06041334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041334.